Adenosylmethionine Disulfate Tosylate Injection 0.5?g ×?5 Vials (Baixino) – Wholesale & Laboratory Use

Adenosylmethionine Disulfate Tosylate Injection 0.5?g ×?5 Vials (Baixino) – Wholesale & Laboratory Use

$1.00

Baixino Adenosylmethionine Disulfate Tosylate Injection contains 0.5?g SAMe per vial (plus solvent). Manufactured by CSPC Tianqing Pharmaceutical Group Co., Ltd., approved under NMPA H20193344. Commonly used in laboratory studies of liver protection, methylation pathways, and cholestatic liver disorders.
?? For laboratory and research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Adenosylmethionine (SAMe) is a key endogenous methyl donor involved in transmethylation and trans-sulfuration reactions. Its disulfate tosylate formulation is used in injectable form to protect liver cell membranes, enhance glutathione and coenzyme A synthesis, and facilitate bile flow. Widely utilized in preclinical research on cholestatic hepatitis, liver fibrosis, and metabolic liver injury.


Adenosylmethionine Disulfate Tosylate Injection Product Specifications

ParameterDetails
Product NameAdenosylmethionine Disulfate Tosylate Injection (Baixino)
Generic NameS-Adenosyl-L-methionine Disulfate Tosylate
CAS Number97540?22?2
Molecular FormulaC??H??N?O?S·C?H?O?S·2H?SO?
Molecular Weight?766.8?g/mol
Dosage FormLyophilized powder for injection with solvent
Dosage per Vial0.5?g SAMe (as disulfate tosylate)
Pack Size5 vials + 5 vials of provided solvent
Approval NumberH20193344
Drug Standard Code86901523002291
ManufacturerCSPC Tianqing Pharmaceutical Group Co., Ltd.
BarcodeNot yet assigned
Storage ConditionsStore at 2–8?°C, protected from light
Intended UseLaboratory research and preclinical liver function studies

Adenosylmethionine Disulfate Tosylate Injection Mechanism of Action

SAMe acts as a universal methyl group donor in vital biochemical pathways, supporting liver cell membrane integrity, glutathione synthesis, and bile detox pathways. It enhances cellular resilience to oxidative and cholestatic injury .


Research Application Areas

  • Models of cholestatic and drug?induced liver injury

  • Prevention of intrahepatic bile stasis and fibrosis

  • Studies of transmethylation and trans?sulfuration pathways

  • Enhancement of antioxidant defenses in hepatocytes

  • Comparative research vs. ursodeoxycholic acid in hepatic protection

Research shows SAMe improves liver tests and reduces fibrosis markers without significant adverse effects in these models ChinaGPDrugBank.


Safety & Handling

  • Adverse Effects: Rare mild gastrointestinal discomfort or sleep disturbances .

  • Reconstitution: Reconstitute each vial with supplied solvent before clinical studies.

  • Handling: Use standard lab PPE—gloves, eyewear, coat; avoid aerosol contact.

  • Storage: Maintain 2–8?°C; do not freeze; protect from light.


Core Keywords

Adenosylmethionine disulfate injection, SAMe injection, H20193344, hepatoprotective injection, liver fibrosis research, methyl donor injection, wholesale SAMe vials, lab-grade SAMe


Research Use Disclaimer

This product is strictly for laboratory and preclinical research use. It is not approved for therapeutic, diagnostic, or veterinary applications. Misuse may bear legal and health consequences. Use only under institutional protocols and regulatory oversight.

Additional information

Weight1 kg
Dimensions26 × 23 × 26 cm

Reviews

There are no reviews yet.

Be the first to review “Adenosylmethionine Disulfate Tosylate Injection 0.5?g ×?5 Vials (Baixino) – Wholesale & Laboratory Use”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare